UPDATE: JPMorgan Downgrades Enanta Pharmaceuticals (ENTA) to Underweight
Tweet Send to a Friend
(Updated - September 26, 2019 4:38 AM EDT)
(updated to add analyst comment)JPMorgan analyst Eric Joseph downgraded Enanta Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)JPMorgan analyst Eric Joseph downgraded Enanta Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
